|
Seegene, a molecular diagnostic company, announced on the 22nd that it recently obtained product registration approval for its own diagnostic kit (product name Allflex SARS-CoV-2/FluA/FluB/RSV Assay) from the Brazilian National Sanitation Agency (ANVISA).
According to Seegene, this diagnostic kit is a diagnostic kit that can check whether you are infected with novel coronavirus infection (Corona 19), influenza A/B flu, and respiratory syncytial virus (RSV) A/B in a single test.
Seegene exported 10 million tests of Corona 19 diagnostic kits from Brazil last year through the Pan American Health Organization (PAHO). The market is expected to expand through the Brazilian ANVISA certification of this simultaneous inspection product.
An official from Seegene said, “We expect this approval to help effectively prepare for the twin demic situation, which is the simultaneous outbreak of COVID-19 and flu in Brazil.”
Meanwhile, Seegen won the final bid for the Peru National Institute of Health (NIH) bid for the Peruvian NIH Screening Project.
The Peruvian government has bid for the products of molecular diagnostic companies for this project, and finally Seegene’s’All-Flex SARS-CoV-2/FluA/FluB/RSV Assay’ kit has been awarded and will be used for large-scale epidemiological investigation to be.
An official from Seegen said, “We plan to solidify our position in Latin America by expanding into a new market through the entry of the Corona 19 Simultaneous Diagnosis Kit following the development of the Latin American market.
